(Q39733997)

14 September 2017

title

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma (English)

1 reference

14 September 2017

9

1 reference

14 September 2017

H Ochiai

1

1 reference

14 September 2017

H Takenobu

2

1 reference

14 September 2017

A Nakagawa

3

1 reference

14 September 2017

Y Yamaguchi

4

1 reference

14 September 2017

M Kimura

5

1 reference

14 September 2017

M Ohira

6

1 reference

14 September 2017

Y Okimoto

7

1 reference

14 September 2017

Y Fujimura

8

1 reference

14 September 2017

Y Kohno

10

1 reference

14 September 2017

A Nakagawara

11

1 reference

14 September 2017

T Kamijo

12

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

18

1 reference

14 September 2017

page(s)

2681-2690

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.22

14 September 2017

exact match

0 references

cites work

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Production of monoclonal antibodies against mammalian Ring1B proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi-1 is essential for the tumorigenicity of neuroblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Cancer epigenomics: DNA methylomes and histone-modification maps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Distinct roles of Polycomb group gene products in transcriptionally repressed and active domains of Hoxb8

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

The fundamental role of epigenetic events in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Cellular memory and hematopoietic stem cell aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Analysis of chromatin structure by in vivo formaldehyde cross-linking.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Stem cell regulation by polycomb repressors: postponing commitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Polycomb complexes and epigenetic states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Principles of tumor suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Polycomb silencers control cell fate, development and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

E2F proteins regulate MYCN expression in neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Stem cells and cancer; the polycomb connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

The Polycomb group protein EZH2 directly controls DNA methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Genetic parameters of neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.22

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.22

1 reference

Dimensions Publication ID

14 September 2017

1042147496

0 references

1 reference